ADVASEPT, created in 2014 (United States), from 17 sister brands and 4958 competing brands. ADVASEPT is owned by Catalent, listed on the stock exchange of New York ADVASEPT belongs to the Drug Manufacturers business sector.
Share price and profitability of the share Catalent (ADVASEPT)
Buy Catalent share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Catalent
(ADVASEPT)
over 5 years*
USD 69.84
Stock market history Catalent (ADVASEPT)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
